Vortex BioSciences
Business Services · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1455 Adams Dr Ste 2010, Menlo Park, Cali...Phone Number
(650) 328-1644Website
www.vortexbiosciences.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Vortex BioSciences
Vortex Liquid Biopsy Solutions Ltd is an innovative leader in circulating tumor cell (CTC) capture technology, dedicated to improving therapeutic decisions and patient outcomes in metastatic cancer treatment. Their flagship product, the VTX-1 Liquid Biopsy System, automates the isolation and collection of viable CTCs from whole blood, providing real-time insights into cancer biology. The company targets researchers and healthcare professionals focused on precision oncology and the development of next-generation anti-metastatic therapies. By facilitating the analysis of intact, viable cancer cells, Vortex aims to enhance the understanding of tumor progression and treatment resistance.Explore more
Vortex BioSciences Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Vortex BioSciences your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Vortex BioSciences launches new products
Check out if Vortex BioSciences is spiking on competitors!
Funding: Get notified immidiatlly once Vortex BioSciences has new funding data
Check if Vortex BioSciences has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Click to see if Vortex BioSciences had a recent Job posting/layoffs
Vortex BioSciences, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Vortex BioSciences recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Vortex BioSciences
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Vortex BioSciences
Compare insights from companies similar to Vortex BioSciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Vortex BioSciences is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Vortex BioSciences is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Vortex BioSciences.
Vortex BioSciences Tech Stack
A closer look at the technologies used by Vortex BioSciences
See more technologies
Most Recent Scoops
Left Company
Executive Move
Left Company
Executive Move
Left Company
Executive Move
Funding
, a biotechnology company, recently secured an investment from EMV Capital. Financial terms of the deal were not disclosed.
Funding
Promotion
Executive Move
Executive Moves, Promotion, Personnel Moves
Vortex BioSciences News & Media
Vortex Biosciences, liquid biopsy for cancer diagnosis, announces experienced start-up leader Dr. Adrian Kinkaid as new CEO
Vortex Biosciences, the cancer diagnosis biotechnology business, has announced the appointment of Dr Adrian Kinkaid as its new Chief Executive Officer. (PRWeb June 02, 2021) Read the full story at https://www.prweb.com/releases/vortex_biosciences_liquid_biopsy_for_cancer_diagnosis_announces_experienced_start_up_leader_dr_adrian_kinkaid_as_new_ceo/prweb17975833.htmVortex Biosciences Announces Publication in Prenatal Diagnosis journal using its technology for enrichment of circulating trophoblasts from maternal blood liquid biopsy
The peer-reviewed publication demonstrates the versatility and flexibility of applications of the Vortex VTX-1 platform. Working in partnership with the team of Prof. Filip Van Nieuwerburgh, at Ghent University in Belgium, this publication describes the use of Vortex's technology to enrich circulating trophoblasts (CTs) from a single tube of maternal blood at week 11-13 of gestation. This is a significant demonstration of the label-free isolation of CTs from maternal blood with the VTX-1 platforEMV Capital takes controlling stake in Vortex Biosciences
EMV Capital has acquired a controlling stake in Vortex Biosciences, a provider of liquid biopsy of circulating tumor cells. No financial terms were disclosed.Vortex Biosciences Receives Investment from EMV Capital
Vortex Biosciences, a San Francisco, CA-based leader in liquid biopsy of circulating tumor cells (CTCs), received an investment from EMV Capital. The amount of the deal was not disclosed. EMV Capital took a controlling stake in the company, which aims to use the proceeds to accelerate its development efforts. The Vortex Biosciences VTX-1 instrument is […] The post Vortex Biosciences Receives Investment from EMV Capital appeared first on FinSMEs.
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Vortex BioSciences
Sign Up For FreeTo access detailed company insights
Vortex Liquid Biopsy Solutions Ltd is an innovative leader in circulating tumor cell (CTC) capture technology, dedicated to improving therapeutic decisions and patient outcomes in metastatic cancer treatment. Their flagship product, the VTX-1 Liquid Biopsy System, automates the isolation and collection of viable CTCs from whole blood, providing rea... Read More
